Cargando…
Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256900/ https://www.ncbi.nlm.nih.gov/pubmed/37305460 http://dx.doi.org/10.1016/j.heliyon.2023.e15876 |
_version_ | 1785057203600752640 |
---|---|
author | Kayali, Zahraa Obaydo, Reem H. Sakur, Amir Alhaj |
author_facet | Kayali, Zahraa Obaydo, Reem H. Sakur, Amir Alhaj |
author_sort | Kayali, Zahraa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10256900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102569002023-06-11 Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] Kayali, Zahraa Obaydo, Reem H. Sakur, Amir Alhaj Heliyon Corrigendum Elsevier 2023-05-04 /pmc/articles/PMC10256900/ /pubmed/37305460 http://dx.doi.org/10.1016/j.heliyon.2023.e15876 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Corrigendum Kayali, Zahraa Obaydo, Reem H. Sakur, Amir Alhaj Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title | Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title_full | Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title_fullStr | Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title_full_unstemmed | Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title_short | Erratum to “Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [Heliyon 9(4) (April 2023) e15260] |
title_sort | erratum to “spider diagram and sustainability evaluation of uv-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation” [heliyon 9(4) (april 2023) e15260] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256900/ https://www.ncbi.nlm.nih.gov/pubmed/37305460 http://dx.doi.org/10.1016/j.heliyon.2023.e15876 |
work_keys_str_mv | AT kayalizahraa erratumtospiderdiagramandsustainabilityevaluationofuvmethodsstrategyforquantificationofaspirinandsildenafilcitrateinthepresenceofsalicylicacidintheirbulkandformulationheliyon94april2023e15260 AT obaydoreemh erratumtospiderdiagramandsustainabilityevaluationofuvmethodsstrategyforquantificationofaspirinandsildenafilcitrateinthepresenceofsalicylicacidintheirbulkandformulationheliyon94april2023e15260 AT sakuramiralhaj erratumtospiderdiagramandsustainabilityevaluationofuvmethodsstrategyforquantificationofaspirinandsildenafilcitrateinthepresenceofsalicylicacidintheirbulkandformulationheliyon94april2023e15260 |